Sartorius expands biopharma manufacturing in Slovenia

By The Science Advisory Board staff writers

May 28, 2021 -- Sartorius plans to expand production facilities for purification products for vaccines and therapies at its facility in Ajdovscina, Slovenia.

The manufacturing and lab space will more than double from 3,000 sq m to 6,200 sq m. In 2021, the company will invest more than 400 million euros ($487.9 million U.S.) in manufacturing capacities around the world to keep up with demand.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.